Patients re-engaging with HIV care in Guatemala: Prioritizing CD4 counting and screening for histoplasmosis and

Narda Medina1, Ana Alastruey-Izquierdo2,3, Oscar Bonilla4

  • 1Asociación de Salud Integral, Guatemala City, Guatemala.

HIV Medicine
|February 17, 2025
PubMed

Insights

Patients re-engaging in care after HIV treatment interruption face high rates of advanced HIV disease and opportunistic infections like tuberculosis and histoplasmosis. Routine CD4 testing is crucial for early detection and intervention.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Immunology

Background:

  • Antiretroviral therapy (ART) discontinuation contributes to advanced HIV disease (AHD) and opportunistic infections.
  • This study examines patients re-engaging in care after ART interruption, comparing them to newly diagnosed HIV patients.

Purpose of the Study:

  • To analyze the burden of tuberculosis and histoplasmosis in patients re-engaging in care versus newly diagnosed HIV patients.
  • To highlight the need for timely CD4 testing and comprehensive diagnostics for advanced HIV disease.

Main Methods:

  • A diagnostic package for opportunistic infections (tuberculosis, histoplasmosis) was implemented in Guatemala (2017-2019).
  • 1379 adults re-engaging in care and 3412 newly diagnosed HIV patients were enrolled across 13 facilities.
  • Data included demographics, lab results, and outcomes.

Main Results:

  • AHD prevalence was high in both groups: 54% in re-engaging patients and 50.1% in newly diagnosed patients.
  • Significant CD4 testing gaps existed: 34.5% un-tested in re-engaging vs. 21.1% in newly diagnosed.
  • Incidence rates for tuberculosis and histoplasmosis were high in re-engaging patients (9.7% and 8.3%) and similar to newly diagnosed patients.

Conclusions:

  • Patients re-engaging in care require similar diagnostic and care pathways as newly diagnosed individuals.
  • Routine, immediate CD4 testing is essential to identify AHD and guide treatment.
  • Early detection and targeted interventions are critical to reduce AIDS-related mortality.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
168
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
128
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
218
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K